November 10, 2025
Her team successfully engineered a specially designed strain of probiotic E. coli that is safe for use in treating brain tumors. This innovative approach harnesses the bacteria’s ability to interact with the tumor environment, where the engineered microbes activate local immune cells in the brain. Their findings reveal that this immune activation plays a key role in the therapeutic effectiveness of the treatment, offering a promising new strategy for targeting tumors through precision microbial engineering.
